Hormone drug eases breast pain for some women
|
Tweet
|
|
Premenopausal women who suffer from breast pain may find relief with a drug called goserelin, or Zoladex, which blocks the female hormone estrogen, UK researchers report.
“This therapy is useful in patients who have failed other treatments for breast pain,” Dr. Robert E. Mansel, from Cardiff University told AMN Health. “It is currently not licensed for this indication, but it can be used at the physician’s discretion.”
Breast pain (mastalgia) is a common problem for many premenopausal women and usually occurs in relation to the menstrual cycle. While most women who have this problem report mild to moderate pain, some report severe pain that causes considerable distress, leading them to seek treatment.
Mansel and his colleagues studied the effects of goserelin on breast pain in 147 premenopausal women with mastalgia. The women received a total of 6 injections of goserelin or the same number of sham injections.
A high percentage of women in both the goserelin group (43 percent) and the sham group (55 percent) discontinued therapy, often due to lack of benefit, the investigators report in the American Journal of Obstetrics and Gynecology.
Still, they say, breast pain scores fell by 67 percent in the goserelin group overall compared with only 35 percent in the sham group.
Six months after the end of treatment, breast pain scores had increased in both groups, but they were still much lower than before treatment.
Goserelin reversibly suppressed levels of female hormones and menstrual periods, the investigators report. Side effects were more common in women receiving goserelin, and included vaginal dryness, hot flushes, oily skin or hair, and decreased interest in sex.
The investigators suggest that goserelin might be useful in premenopausal women with severe breast pain but it should only be used for a short period of time—up to 6 months—because of the drug’s potential to cause bone loss.
SOURCE: American Journal of Obstetrics and Gynecology, December 2004.
Revision date: June 18, 2011
Last revised: by Janet A. Staessen, MD, PhD
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Obesity not always tied to higher heart risk: study
- Full Story - - »»»
Anti-obesity proposal fails again at McDonald’s
- Full Story - - »»»
Scientists turn skin cells into beating heart muscle
- Full Story - - »»»
Too many people get angioplasties, study suggests
- Full Story - - »»»
Viewers’ family background affects how they react to MTV shows ‘16 and Pregnant,’ ‘Teen Mom’
- Full Story - - »»»
Weight management in pregnancy with diet is beneficial and safe and can reduce complications
- Full Story - - »»»

